OUR

LEADERSHIP TEAM

Our Leadership team is comprised of a mix of innovative, experienced, and scientific-minded leaders who have set the tone for GenomOncology's ambitious and driven culture.

BRAD WERTZ

brad3.jpg

Chief Executive Officer

Formerly the President and COO of Rosetta, Brad Wertz helped grow the company from $115M to $225M before its sale to Publicis. Before Rosetta, He served as COO for Brulant and also held senior executive positions at several other startups including bioinformatics company Acero. 

GINA DROBNICK

gina.png

Chief Operating Officer

Gina Drobnick has more than 25 years of experience as both a management consultant and an operations executive. Gina also worked at Ernst & Young, Arthur Andersen, Brulant as an Associate Partner in their creative group, and Level Seven, Inc. as their Chief Operating Officer.

JUSTIN YEAKLEY

justin2.png

VP of Product Development

Justin Yeakley supports and supervises all activities related to the design, development, and implementation of GO's suite of products. Justin has over 12 years of software development and leadership experience and was previously Director of Application Development at Rosetta.

IAN MAURER

ian2.jpg

Chief Technology Officer

Ian Maurer leads the full lifecycle of application design, architecture, development, and quality assurance. Ian has over 17 years of software development and leadership experience working for Lockheed Martin, Ernst & Young, Brulant, and Rosetta.

TERESA FLETCHER, CHP

teresa2.jpg

Senior VP of Business Development

Teresa Fletcher is a seasoned business development professional with a deep understanding of oncology and the healthcare ecosystem. Teresa has over 17 years experience with enterprise solution sales holding positions at various healthcare startups within sales and customer management. 

JEFF SMITH

jeff.png

VP of Finance

Jeff Smith has more than 24 years of experience in the areas of accounting, finance, operations, and business development. Prior to GO, Jeff was the Chief Financial Officer for several Private Equity backed lower middle-market companies both domestically and abroad.

Office

1138 West 9th St Suite 400

Cleveland, OH 44113, USA

(440) 617-6087

CONTACT US

© 2020 GenomOncology LLC